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and kDivision of Molecular Cardiovascular Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OhioABSTRACT We investigated the influence of cardiac myosin binding protein-C (cMyBP-C) and its constitutively unphosphory-
lated status on the radial and longitudinal stiffnesses of the myofilament lattice in chemically skinned myocardial strips of the
following mouse models: nontransgenic (NTG), effective null for cMyBP-C (t/t), wild-type cMyBP-C expressed into t/t (WTt/t),
and constitutively unphosphorylated cMyBP-C (AllP-t/t). We found that the absence of cMyBP-C in the t/t and the unphosphory-
lated cMyBP-C in the AllP-t/t resulted in a compressible cardiac myofilament lattice induced by rigor not observed in the NTG and
WTt/t. These results suggest that the presence and phosphorylation of the N-terminus of cMyBP-C provides structural support
and radial rigidity to the myofilament lattice. Examination of myofilament longitudinal stiffness under rigor conditions demon-
strated a significant reduction in cross-bridge-dependent stiffness in the t/t compared with NTG controls, but not in the AllP-t/t
compared with WTt/t controls. The absence of cMyBP-C in the t/t and the unphosphorylated cMyBP-C in the AllP-t/t both resulted
in a shorter myosin cross-bridge lifetime when myosin isoform was controlled. These data collectively suggest that cMyBP-C
provides radial rigidity to the myofilament lattice through the N-terminus, and that disruption of the phosphorylation of
cMyBP-C is sufficient to abolish this structural role of the N-terminus and shorten cross-bridge lifetime. Although the presence
of cMyBP-C also provides longitudinal rigidity, phosphorylation of the N-terminus is not necessary to maintain longitudinal rigidity
of the lattice, in contrast to radial rigidity.INTRODUCTIONThe cardiac isoform of myosin binding protein-C (cMyBP-
C) has drawn considerable attention since it was first
recognized that mutations in the human MYBPC3 gene
underlie the development of a high percentage of cases of
familial cardiomyopathy (1–4). A significant reduction in
cMyBP-C density has now been observed in some humans
carrying mutant alleles for MYBPC3 (5,6). These findings
heighten the importance of understanding the functional
and structural effects of a reduced content of cMyBP-C
while we continue to discover the physiological function
of cMyBP-C and its phosphorylation.
cMyBP-C is normally incorporated into the thick filament
at regular 43 nm intervals (7,8), and its complete absence
from the sarcomere leads to an atypical dilated phenotype
in three independently developed mouse models lacking
cMyBP-C, labeled / for the genetic null and t/t for the
effective null (9–11). Compared with nontransgenic (NTG)
controls, the absence of cMyBP-C in structurally intact
cardiac myofilaments leads to reduced rigor cross-bridge-
dependent stiffness and thick filament stiffness (12,13).
Furthermore, the absence of cMyBP-C leads to greater
myofilament disorder (14,15) and an expanded (14) or
possibly unchanged (12) myofilament lattice spacing.Submitted March 15, 2011, and accepted for publication August 24, 2011.
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0006-3495/11/10/1661/9 $2.00The C-terminus of cMyBP-C binds to the myosin rod,
titin, and other cMyBP-Cs within the thick filament back-
bone (16–18). These binding properties of the C-terminus
appear to underlie a structural role in stabilizing and stiff-
ening the thick filament, thereby facilitating force transmis-
sion between the acto-myosin cross-bridge and the M-line
(13). In contrast, the N-terminus of cMyBP-C is not incor-
porated as part of the thick filament backbone and possesses
multiple phosphorylation sites as well as binding sites to
myosin S2 and actin (17,19,20). The arrangement of myosin
heads along the thick filament and the kinetics of acto-
myosin cross-bridges are sensitive to cMyBP-C phosphory-
lation (19–21), and evidence suggests that cMyBP-C
phosphorylation modulates sarcomere function via its direct
influence on myosin head position, myofilament lattice
spacing, and/or thin filament activation (4,15,20–26).
Using the t/t mouse as a background, we developed
a transgenic mouse line to test the effects of unphosphory-
lated cMyBP-C on sarcomere mechanical properties related
to the possible structural role of cMyBP-C in the context
of an intact myofilament lattice. The transgenic mouse
expresses a cMyBP-C, termed AllP-t/t, that has five possible
phosphorylation sites (Thr-272, Ser-273, Thr-281, Ser-282,
and Ser-302) exchanged with Ala to mimic a nonphosphory-
lated cMyBP-C (27). Compared with control mice express-
ing the wild-type cMyBP-C in the t/t background (WTt/t),
AllP-t/t hearts develop an atypical dilated cardiomyopathy
(9–11,27).doi: 10.1016/j.bpj.2011.08.047
1662 Palmer et al.In this study, we examined t/t, AllP-t/t, and control mice
expressing WT cMyBP-C to elucidate the structural role
of cMyBP-C in providing radial and longitudinal stiffness
to the myofilament lattice. We report that the maintenance
of myofilament order and also possibly interfilament lattice
rigidity are dependent on the presence of the N-terminus of
cMyBP-C and/or its phosphorylation capacity. We also find
that the absence of cMyBP-C or its effective dephosphory-
lation leads to a shorter myosin cross-bridge lifetime (ton).MATERIALS AND METHODS
Mouse models
All procedures were reviewed and approved by the institutional animal care
and use committees of the Cincinnati Children’s Hospital Medical Center
and University of Vermont Medical School, and were in compliance with
the Guide for the Use and Care of Laboratory Animals published by the
National Institutes of Health. The mice used in this study were generated
as previously described (27,28). A cohort of WTt/t and AllP-t/t mice
received 3 mg/g body weight L-thyroxine (T4, T-2501; Sigma-Aldrich,
St. Louis, MO) by six consecutive daily intraperitoneal injections of
200 mL of 0.9% saline þ 10 mM NaOH. This was done to mimic hyperthy-
roidism and elicit expression of cardiac a-MyHC. A similar T4 treatment in
the t/t mice led to>50%mortality, which led us to choose another treatment
in these mice. A cohort of NTG and t/t mice were fed an iodine-deficient,
0.15% 6-n-propyl-2-thiouracil (PTU) diet (No. TD97061; Harlan-Teklad)
for at least 10 weeks, which induced hypothyroidism and a downregulation
of cardiac a-MyHC expression.Isolated cardiomyocytes
Mouse left ventricle (LV) cardiomyocytes were isolated by retrograde
perfusion with collagenase solution as described elsewhere (13), but
without blebbistatin. Cardiomyocytes were observed with a 40 objective
on an inverted microscope (Nikon Diaphot) while bathed in normal
Tyrode’s solution containing (in mmol/L) 137 NaCl, 5.4 KCl, 0.5 MgCl2,
10 HEPES, 5.5 glucose, 0.5 Probenecid at pH 7.4. We detected the resting
sarcomere length at 37C using Fourier transforms of the digital image
(IonOptix, Milton, MA). At least 10 cardiomyocytes were used to detect
the average sarcomere length for nine NTG, six t/t, seven WTt/t, and 10
AllP-t/t hearts.Quantification of site-specific phosphorylation
Phosphorylated amino acids were identified at four specific sites within
cMyBP-C isolated from NTG expressing WT MyBP-C, and the degree of
phosphorylation was quantified by label-free liquid chromatography-mass
spectrometry. A thorough explanation of these methods is provided in the
Supporting Material and elsewhere (29).Solutions for skinned strips
Chemicals and reagents were obtained from Sigma (St. Louis, MO) unless
otherwise noted. We formulated the solution concentrations (expressed in
mmol/L unless otherwise noted) by solving equations describing ionic equi-
libria according to Godt and Lindley (30). The relaxing solution consisted
of pCa 8.0, 5 EGTA, 5 MgATP, 1 Mg2þ, 0 Pi, 40 phosphocreatine (PCr),
240 U/mL creatine kinase (CK), ionic strength 190, pH 7.0. The activation
solution was the same as the relaxing solution but with pCa 4.5. The rigor
solution was the same as the activating solution but with no ATP. The
skinning solution was the same as the relaxing solution but without PCrBiophysical Journal 101(7) 1661–1669or CK and with 10 mg/mL leupeptin, 1% Triton-X100 wt/vol, and subse-
quently 50% glycerol wt/vol. The storage solution was the same as the
relaxing solution but without PCr or CK and with 10 mg/mL leupeptin
and 50% glycerol wt/vol.X-ray diffraction
Papillary muscles were dissected to no less than 1 mm diameter and chem-
ically skinned for 2 h at room temperature, stored at 20C for no more
than 4 days, and stretched to 2.2–2.4 mm sarcomere length. We obtained
equatorial x-ray diffraction patterns at room temperature using the BioCAT
small-angle x-ray diffraction facility on beamline 18ID at the Advanced
Photon Source (Argonne, IL) as previously described (31,32). The separa-
tions of the 1,0 equatorial reflections were measured by two independent
observers and then converted into the mean distance between planes of
thick filaments (d1,0) (31).Length perturbation analysis
LV skinned myocardial strips were studied as previously described (33,34).
Papillary muscles were dissected to yield at least two thin strips (~140 mm
diameter, ~800 mm length) with longitudinally oriented parallel fibers,
skinned for 2 h at room temperature, and stored at –20C for no more
than 4 days. At the time of study, aluminum T-clips were attached to the
ends of a strip ~300mmapart. The stripwasmounted between a piezoelectric
motor (Physik Instrumente, Auburn, MA) and a strain gauge (SensorNor,
Horten, Norway), lowered into a 30 mL droplet of relaxing solution (pCa
8.0) maintained at 17C, and incrementally stretched to 2.2 mm sarcomere
length as measured by digital Fourier transform. Sinusoidal length pertur-
bations of amplitude 0.125% strip length were applied at 0.125–250 Hz
as previously described (33,34). The elastic and viscous moduli were
measured from the in-phase and out-of-phase portions of the tension
response to length perturbation. The fitting of the frequency dependence
of the elastic and viscous moduli to a mathematical model provided
a measure of myosin ton as demonstrated previously (35).Analysis
Multiple measurements from the same heart were averaged to provide
a single measure for that heart. All data are presented as the mean 5 SE,
and significance by statistical tests are reported at the p < 0.05 and
p < 0.01 levels.RESULTS
Characteristics of mouse hearts
The LVs of the t/t and AllP-t/t mice were significantly larger
than those of their respective NTG and WTt/t controls
(Table 1). Despite a normal abundance of cMyBP-C in the
AllP-t/t, these hearts developed an atypical dilated cardio-
myopathy similar to that developed in the / and t/t
mice lacking cMyBP-C, as reported previously (9–11,27).
MyHC isoform profiles from these LVs are illustrated in
Fig. 1 A and demonstrated significant concentrations of
b-MyHC in the t/t (~40%) and AllP-t/t (~40%). PTU treat-
ment in the NTG and t/t led to near 100% incorporation
of b-MyHC (Fig. 1 B). Thyroxine (T4) treatment in the t/t
and AllP-t/t induced a greater expression of a-MyHC
compared with b-MyHC (Fig. 1 B). The concentrations of
a-MyHC in the AllP-t/tT4 (~90%) were comparable to
TABLE 1 Mouse characteristics, cardiomyocyte unloaded sarcomere length, activated myofilament tension, and myosin
lifetime (ton)
NTG (n ¼ 7) t/t (n ¼ 9) WTt/t (n ¼ 8) AllP-t/t (n ¼ 9)
Age (weeks) 28.75 4.3 24.35 3.5 22.75 2.3 29.95 4.0
Body mass (g) 30.05 1.5 31.15 0.7 31.55 0.8 32.45 1.3
LV/body (mg/g) 3.575 0.26 6.655 0.32* 3.705 0.19 5.015 0.26*
RVþLV/body (mg/g) 4.585 0.17 8.485 0.47* 4.815 0.20 6.245 0.32*
Sarcomere length (mm) 1.715 0.02 1.605 0.05* 1.945 0.03 1.745 0.02**
Tmin (mN.mm
2) 2.245 0.25 2.725 0.32 2.365 0.50 1.985 0.33
Tdev (mN.mm
2) 13.65 1.8 11.95 1.2 16.05 1.3 15.35 1.5
ton (ms) 11.05 0.8 14.75 1.0* 11.55 0.6 10.55 0.5
NTGPTU (n ¼ 5) t/tPTU (n ¼ 6) WTt/tT4 (n ¼ 4) AllP-t/tT4 (n ¼ 5)
ton (ms) 60.65 3.3 39.35 2.6* 10.55 1.8 7.6 5 0.6
y
LV and added right ventricle (RV) weights were greater in the t/t compared with NTG and in the AllP-t/t compared with WTt/t. *Different from respective
control (p < 0.05); **p < 0.01; ydifferent from WTt/tT4 controls at p ¼ 0.085 and from AllP-t/t at p < 0.05.
cMyBP-C and Myosin Cross-Bridge Lifetime 1663WTt/tT4 (~90%) with T4 treatment and WTt/t (~95%)
without T4 treatment.
The degree of phosphorylation of Ser-273, -282, -302,
and -307 in the endogenous protein of the NTG, presented
in Table 2, was determined by mass spectroscopy (see Sup-
porting Material for raw data). Assuming that these four
serines constitute the phosphorylatable sites of cMyBP-C,
the percentage of cMyBP-C that is totally nonphosphory-
lated and singly, doubly, triply, and quadruply phosphory-
lated would be 0%, ~15%, ~55%, ~27.5%, and ~2.5%,
respectively. This phosphorylation profile is consistent
with that previously observed for the NTG and WTt/t using
isoelectric focusing gels (27).
Ser-273, -282, and -302 are homologous to three of the
five sites exchanged with Ala in the AllP-t/t. Although the
probability of having Ser-273, -282, and -302 phosphory-
lated is low (~24%), the majority of the endogenous protein
(~76%) contains phosphorylation on Ser-273 and -282. We
infer this phosphorylation profile to be that of the NTG and
WTt/t, in contrast to the fully dephosphorylated profile of the
AllP-t/t.Myofilament lattice spacing
Small-angle x-ray diffraction was used to detect the
mean distance between planes of thick filaments (Fig. 2 A),
which served as a quantitative index of myofilament lattice
spacing, d10. Raw x-ray intensity profiles under relaxedNTG       t/t WTt/t AllP-t/t
* *
A B
NTGPTU t/tPTUconditions (Fig. 2 B) demonstrated qualitatively a greater
degree of myofilament lattice disorder in the t/t and AllP-t/t,
in similarity to that quantified and reported previously
(14,15). Example x-ray intensity profiles for all four popula-
tions under the three conditions examined are presented in
the Supporting Material. As can be seen in Fig. 2, Fig. S3,
and Fig. S4, the d1,0 and d1,1 peaks are less prominent and
broader in the t/t and AllP-t/t compared with the NTG and
WTt/t. These features are indicative of greater myofilament
disorder reported previously for the sarcomere of the t/t (9)
and possibly in concert with myosin head disorder as occurs
with no MyBP-C or dephosphorylation of MyBP-C detected
by electron microscopy (21). At a sarcomere length of 2.2–
2.4 mm and under maximum calcium-activated conditions
(pCa 4.5) or rigor conditions, the myofilament lattice
spacing of the t/t and AllP-t/t was less (p < 0.05 by two-
way repeated-measures analysis of variance) than their
respective NTG and WTt/t controls (Fig. 2 C). Of interest,
both the t/t and AllP-t/t showed shorter sarcomere lengths
in unloaded cardiomyocytes (Table 1), as reported previ-
ously for / and t/t (13,36), and also more compressed
myofilament lattices when sarcomeres were set to 2.2–
2.4 mm length and calcium activated (Fig. 2). These data
are internally consistent with an inverse relationship
between myofilament lattice spacing and sarcomere length
in these populations (31,37,38). Specifically, resting sarco-
mere length in unloaded single cardiomyocytes of the t/t
and AllP-t/t was significantly shorter than that of NTG andWTt/tT4 AllP-t/tT4
FIGURE 1 MyHC isoform profiles in mouse LV.
(A) Gel electrophoresis stained with Coomassie
Blue reveals the relative contents of a-MyHC and
b-MyHC in NTG, t/t, WTt/t, and AllP-t/t genotypes
(27). LVs from NTG and WTt/t contained an ~90/
10 ratio of a/b-MyHC, and LVs of t/t and AllP-t/t
contained an ~60/40 ratio of a/b-MyHC. (B)
NTG and t/t mice made hypothyroid by a PTU
diet expressed predominantly (nearly 100%) b-
MyHC. WTt/t and AllP-t/t mice made hyperthyroid
by thyroxine (T4) treatment expressed predomi-
nantly (nearly 100%) a-MyHC.
Biophysical Journal 101(7) 1661–1669
TABLE 2 Phosphorylated peptides observed and degree of
phosphorylation determined for endogenous cMyBP-C
isolated for NTG mice
Phosphorylated
amino acid Phosphopeptide observed
Phosphorylation
(%5 SD)
Ser-273 272TSpLAGAGR279 765 11
271RTSpLAGAGR279
Ser-282 281TSpDSHEDAGTLDFSSLLK298 1005 0
280RTSpDSHEDAGTLDFSSLLK298
Ser-302 299KRDSpFR304 315 12
Ser-307 305RDSpKLEAPAEEDVWEILR322 115 3
1664 Palmer et al.WTt/t controls (Table 1). We would therefore expect a more
compressed lattice from a sarcomere that is stretched to 2.2–
2.4 mm when its unloaded sarcomere length is relatively
shorter, as was the case for the t/t and AllP-t/t.
Rigor compressed the lattice to a greater extent (p < 0.05
by two-way repeated-measures analysis of variance) than
did calcium activation (Fig. 2 D). Rigor conditions in skel-
etal muscle have been shown to impose a radial compressive
force on the myofilament lattice, presumably due to a radial
component of the rigor cross-bridge force as it adopts a post-
power-stroke state while bound to actin (39,40). We found
that the skinned mouse cardiac myofilament lattice is not
compressed under rigor versus calcium-activated conditions
in the NTG and WTt/t controls, as was reported previously
for skinned rat myocardium (41). These findings imply
that the presence of WT cMyBP-C and its in vivo phosphor-
ylation in the NTG and WTt/t provide mechanical support
for the myofilament lattice of cardiac muscle, and that the
N-terminus of cMyBP-Cmay effectively provide a structural
strut, either directly or indirectly through the myosin head,
between myofilaments.Biophysical Journal 101(7) 1661–1669Effects of cMyBP-C on cross-bridge lifetime
We performed small length perturbation analysis on skinned
myocardial strips of NTG versus t/t, and WTt/t versus AllP-t/
t to examine the effects of MyBP-C and its unphosphory-
lated state on myofilament mechanical characteristics under
activated and rigor conditions. The elastic and viscous
moduli recorded at maximum calcium activation are pre-
sented in Fig. 3. Over several frequencies examined, the
elastic and viscous moduli were significantly lower in the
t/t compared with NTG controls (Fig. 3, A and B). The
cross-bridge ton, which qualitatively is reciprocally related
to the frequency of peak viscous modulus (35), was signif-
icantly prolonged in the t/t compared with NTG, but was
similar between AllP-t/t and WTt/t (Table 1).
The myosin cross-bridge lifetime, ton, is known to be
significantly longer in b-MyHC compared with the
a-MyHC normally expressed in adult mouse hearts (42–
44). However, it is difficult to detect and compare ton for
mouse myosin isoform using the laser trap unless MgATP
is reduced substantially below saturating concentrations to
prolong the ton. Using laser trap techniques at saturating
levels of MgATP, Palmiter et al. (45) observed ton in rabbit
b-MyHC to be double that of a-MyHC. We previously esti-
mated ton inmouse b-MyHC (~43ms) to be four times longer
than that of a-MyHC (~11 ms) using conditions, including
a saturating MgATP concentration, similar to those used in
this study (35). Because both the t/t and AllP-t/t express
~40% b-MyHC (compared with nearly 95–100% a-MyHC
in the NTG andWTt/t), and because of the linear relationship
between a/b-MyHC ratio and myosin kinetics (46,47), we
would have expected to find similarly prolonged ton at
~24 ms for both the t/t and AllP-t/t when compared with theirFIGURE 2 Small-angle x-ray diffraction detec-
tion of myofilament lattice spacing. (A) This
cartoon of a myofilament lattice cross section illus-
trates the planes of thick filaments and thin fila-
ments separated by distances termed d1,0 and
d1,1, respectively. (B) The distance from the origin
to peaks in the x-ray intensity profile along the
equator provides a measure of the mean distance
between planes of thick filaments. Under relaxed
conditions, the diffraction peaks indicating d1,0
and d1,1 profiles of t/t and AllP-t/t tended to be
broader and weaker, which are characteristics
consistent with increased paracrystalline disorder
in the myofilament lattice. (C) Myofilament lattice
spacing was compressed in t/t and AllP-t/t
compared with respective controls. *Different
from respective control under the same conditions
(p < 0.05), **p < 0.01. (D) Rigor induced signif-
icant compression of the myofilament lattice in the
t/t and AllP-t/t compared with activated conditions.
*Different from no change by paired t-test (p <
0.01); n ¼ 7 NTG, 5 t/t, 8 WTt/t, and 6 AllP-t/t.
FIGURE 3 Frequency characteristics of the elastic and viscous moduli at maximum calcium activation and 17C. (A and B) Values for the elastic and
viscous moduli were significantly reduced in the t/t myofilaments over several frequencies compared with NTG. The frequency characteristics of the moduli
were also shifted to lower frequencies in the t/t, as indicated qualitatively by the position of the peak in the viscous modulus. (C and D) Elastic and viscous
moduli in AllP-t/t are similar to those of WTt/t. *Different from control population by t-test (p < 0.05); n ¼ 8 NTG, 8 t/t, 8 WTt/t, and 8 AllP-t/t.
cMyBP-C and Myosin Cross-Bridge Lifetime 1665respective controls with ton ~11 ms. Instead, we found ton
~15 ms for t/t and ~11 ms AllP-t/t, which are much shorter
than the 24 ms predicted based on the MyHC isoform. These
results suggest that cross-bridge-dependent mechanics,
which dominate the mechanical response to length perturba-
tions at maximum calcium activation, do not strictly depend
on the MyHC isoform, and that ton may be shortened by the
absence of cMyBP-C in the t/t and by the unphosphorylated
state of cMyBP-C in the AllP-t/t.
To further examine the influence of MyBP-C on myosin
cross-bridge ton without the complication of differential
MyHC isoform profiles, we calculated myosin cross-bridge
ton in NTG and t/t mice that were made hypothyroid by the
PTU diet and thereafter expressed predominantly b-MyHC
(Fig. 1 B). We performed small length perturbation analysis
under the same conditions described above. The mean cross-
bridge ton was significantly shorter (i.e., shortened by 1/3) in
the t/tPTU compared with the NTGPTU (Table 1). Because
both the NTGPTU and t/tPTU express 90–100% b-MyHC,
we attribute the shorter ton in the t/tPTU to its lack of
cMyBP-C. We also estimated myosin cross-bridge ton in
the WTt/t and AllP-t/t that had been treated with T4, which
induced an increased expression of a-MyHC (Fig. 1 B).
Myosin ton was shorter in the AllP-t/tT4 compared with
WTt/tT4 and compared with AllP-t/t without T4 treatment
(Table 1). These data confirm that myosin ton is shortenedby the absence of the cMyBP-C in the t/t and by the unphos-
phorylated state of cMyBP-C in the AllP-t/t.
Under rigor conditions, the t/t mice demonstrated signif-
icantly reduced elastic and viscous moduli compared with
NTG controls over the majority of frequencies examined
(Fig. 4 A), as reported previously (12,34). The elastic and
viscous moduli were not different between the AllP-t/t and
WTt/t (Fig. 4, C and D), which would indicate that the
mutations in the cMyBP-C N-terminus did not significantly
influence the longitudinal viscoelastic properties of the
sarcomere.DISCUSSION
There are three important findings of this study: 1), Both the
t/t and AllP-t/t demonstrated significant myofilament lattice
compression due to rigor compared with controls. This
result may be due to the lack of cMyBP-C (t/t) and the
unphosphorylated state of cMyBP-C (AllP-t/t) indepen-
dently leading to an abnormally high radial compressibility
of the cardiac myofilament lattice by rigor cross-bridges,
although it is also possible that the ~40% density of b-
MyHC in these populations may underlie the higher
compressibility compared with the controls, which comprise
nearly 100% a-MyHC. 2), The absence of cMyBP-C led to
abnormally lower longitudinal stiffness of the sarcomere.Biophysical Journal 101(7) 1661–1669
FIGURE 4 Frequency characteristics of the elastic and viscous moduli under rigor conditions and 17C. (A and B) Values for the elastic and viscous moduli
were significantly reduced in the t/t myofilaments over several frequencies compared with NTG. The frequency characteristics of the moduli were also shifted
to lower frequencies in the t/t. (C and D) Elastic and viscous moduli in AllP-t/t are similar to those of WTt/t. *Different from control population by t-test
(p < 0.05); n ¼ 8 NTG, 8 t/t, 8 WTt/t, and 8 AllP-t/t.
1666 Palmer et al.3), The absence and unphosphorylated state of cMyBP-C
also led to significantly shorter cross-bridge ton indepen-
dently of the MyHC isoform.N-terminus, lattice structure, and compressibility
Previous findings from skinned skeletal muscle suggest that
calcium activation and rigor conditions compress the
myofilament lattice due to acto-myosin cross-bridge forma-
tion (39,40,48,49), whereas observations from skinned or
intact cardiac muscle suggest no differences in interfilament
spacing under relaxed, activated, or rigor conditions (38,41).
The greater relative compressibility of the skeletal myofila-
ment lattice compared with the cardiac myofilament lattice
due to cross-bridge formation may reflect the greater
tendency for cardiac myosin to bind weakly to the actin fila-
ment under relaxed and partially activated conditions (41).
Other structural differences between skeletal and cardiac
myofilaments that could be responsible for these disparate
observations in myofilament lattice compressibility are the
smaller size, smaller number, and possibly dissimilar func-
tion of myosin-binding protein-C in the skeletal muscle
sarcomere compared with cardiac muscle (8).
The x-ray data presented here suggest a more compress-
ible myofilament lattice in the t/t and AllP-t/t under rigor
conditions, which suggests that the presence of cMyBP-CBiophysical Journal 101(7) 1661–1669or the phosphorylation of Ser-273 and -282 contribute
significantly to the radial stiffness of the cardiac myofila-
ment lattice. However, we cannot exclude the possibility
that the incorporation of b-MyHC in the t/t and AllP-t/t
results in greater radial compression during rigor induction
or leads to greater radial compliance of the lattice, although
there is no evidence for or against either possibility at this
time. There is evidence for similar myofilament lattice
spacing for a-MyHC versus b-MyHC in intact ferret
ventricular muscle under relaxed conditions (50). In addi-
tion, we would not expect the incorporation of b-MyHC
to lead to the greater myofilament disorder we observed in
the t/t and AllP-t/t. We are therefore biased toward the
cMyBP-C explanation regarding increased lattice compli-
ance in the t/t and AllP-t/t, although further studies are
clearly warranted. Based on our current results, one might
expect that a fully phosphorylated cMyBP-C, such as that
provided by the AllPþt/t mouse bearing aspartic acid resi-
dues instead of alanines at the sites targeted in the AllP-t/t,
would lead to a more rigid myofilament lattice and greater
myofilament order like that observed in the NTG and
WTt/t (28). This possible structural result for AllPþt/t mice
could underlie in part the rescue of t/t with the fully phos-
phorylated cMyBP-C (28).
In another study of whole-heart function in the same pop-
ulations used here (51), both the t/t and AllP-t/t demonstrated
cMyBP-C and Myosin Cross-Bridge Lifetime 1667blunted responses to isoproterenol, which initiates protein
kinase-A (PKA)-mediated phosphorylation of several myo-
fibrillar proteins, including cMyBP-C. Other studies have
also demonstrated blunted cardiac myofibrillar response to
PKA in the cMyBP-C knockout mouse (23,26). Our data
correlate with these findings and suggest the possibility that
reduced PKA responsiveness in the t/t and AllP-t/t are due
to a loss of myofilament lattice radial stiffness that occurs
with missing or unphosphorylatable Ser-273 and -282 of
cMyBP-C.C-terminus, longitudinal stiffness,
and cross-bridge lifetime
Previous studies into the functional effects of an undetect-
able amount (t/t) or a true knockout (/) of cMyBP-C in
the mouse revealed the development of a cardiomyopathy
characterized in part by reduced rates of relaxation (9–11).
A shorter myosin ton due to the absence of cMyBP-C would
contribute to a faster rate of relaxation in the/ (10,11,36)
and t/t (9,33,34). Our measure of a shorter myosin ton is
therefore not consistent with slowed relaxation rates due
to a lack of MyBP-C. However, the enhanced rate of force
redevelopment in myofilaments of the / (15,52,53),
unloaded shortening velocity in the / (54) and t/t (33),
and frequency of oscillatory work in the t/t (34) are consis-
tent with our finding of a shorter ton due to a lack of
cMyBP-C. We propose that cMyBP-C normally provides
a significant elastic and viscous load, which would inhibit
contractile performance and yet provide a means of storing
elastic recoil energy to facilitate subsequent relaxation
function. In other words, we believe that the presence of
cMyBP-C allows for storage of mechanical recoil energy
in the sarcomere. The greater recoil energy stored during
systole in the stiffer cMyBP-C-containing sarcomere would
in turn drive the relaxation function more so than in the
compliant cMyBP-C-lacking sarcomere.
A diminished and abbreviated systolic elastance has been
observed in/ and t/t mice but not in AllP-t/t or other mice
with clearly developed cardiomyopathies (33,51). The
abbreviated systolic elastance characteristic appears to be
due to the missing C-terminus, which is normally incorpo-
rated into the thick filament and provides significant struc-
tural support to account for ~40% of thick filament
stiffness (13). We report here that myofilament stiffness,
measured as the elastic moduli at very high frequencies, is
significantly lower in the t/t but not different in AllP-t/t
compared with controls expressing WT cMyBP-C. One
important structural dissimilarity between the t/t and the
NTG, AllP-t/t, and WTt/t is again the missing C-terminus
in the t/t. A more compliant thick filament, as observed in
the t/t, would theoretically reduce the backward-going or
resistive strain on the myosin head in its post-power-stroke
confirmation. The result at the single-molecule level (55,56)
would be a faster ADP off-rate and a shorter ton, as weobserved here in the t/t and AllP-t/t. In this case, we might
conclude that the more compliant thick filament in the t/t,
and possibly the greater radial compliance in the t/t and
AllP-t/t, would shorten or abbreviate myosin cross-bridge ton.CONCLUSION
Collectively, our data suggest a structural role for cMyBP-C
that provides mechanical rigidity to the myofilament lattice
as well as the thick filament (13). We propose that the
cMyBP-C N-terminus must be structurally intact and phos-
phorylated at Ser-273 and -282 in the mouse cMyPB-C to
maintain normal myofilament order and possibly also lattice
spacing. We propose that the increased stiffness of the thick
filament and possibly also the lattice provided by cMyBP-C
lead to a greater amount of stored recoil energy available to
facilitate later relengthening of the sarcomere. Our results
regarding the myosin cross-bridge lifetime suggest that
intact and partially phosphorylated cMyBP-C, which is
available in NTG and WTt/t mice, prolongs the cross-bridge
lifetime, ton, by providing a particular deformation of
myosin head during the post-power stroke that is more
likely to prolong the ADP state or slow ATP binding, or
both. Finally, haploinsufficiency due to a mutant allele for
MYBPC3, as has been found in humans (5,6), may con-
tribute to the development of cMyBP-C-related cardiomy-
opathies resulting in part from the loss or degradation of
cMyBP-C structure and function reported here.SUPPORTING MATERIAL
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